TY - JOUR
T1 - Assessment of the Angiogenic Potential of 2-Deoxy-D-Ribose Using a Novel in vitro 3D Dynamic Model in Comparison With Established in vitro Assays
AU - Dikici, Serkan
AU - Aldemir Dikici, Betül
AU - Bhaloo, Shirin Issa
AU - Balcells, Mercedes
AU - Edelman, Elazer R.
AU - MacNeil, Sheila
AU - Reilly, Gwendolen C.
AU - Sherborne, Colin
AU - Claeyssens, Frederik
N1 - Funding Information:
SD and BA were funded by the Republic of Turkey—The Ministry of National Education. We acknowledge Battelle for providing financial support to this project. EE was supported in part by a grant from the US National Institute of Health (Grant No. R01 49039). MB was partially funded by Spain Minister of Economy (SAF2017-84773-C2-1-R), Fundacion Empreses IQS and the Global Co-Creation Lab. We also acknowledge the Engineering and Physical Sciences Research Council (Grant No. EP/I007695/1) and the Medical Research Council (Grant No. MR/L012669/1) for funding the equipment used in this study.
Funding Information:
The authors are grateful to the Turkish Ministry of National Education for the funding of PhD award to SD and BA and Battelle for providing financial support to this project. We also acknowledge the Engineering and Physical Sciences Research Council (Grant No. EP/I007695/1) and the Medical Research Council (Grant No. MR/L012669/1) for funding the equipment used in this study. M.B. thank Spain Minister of Economy (SAF2017-84773-C2-1-R), Fundacion Empreses IQS and the Global Co-Creation Lab for partial support of this research. E.R.E. thanks US National Institute of Health (Grant No. R01 49039) for providing financial support. We thank Dr. Michael J. Tarkanian for providing technical support on 3D printing of the chambers.
Publisher Copyright:
© Copyright © 2020 Dikici, Aldemir Dikici, Bhaloo, Balcells, Edelman, MacNeil, Reilly, Sherborne and Claeyssens.
PY - 2020/1/17
Y1 - 2020/1/17
N2 - Angiogenesis is a highly ordered physiological process regulated by the interaction of endothelial cells with an extensive variety of growth factors, extracellular matrix components and mechanical stimuli. One of the most important challenges in tissue engineering is the rapid neovascularization of constructs to ensure their survival after transplantation. To achieve this, the use of pro-angiogenic agents is a widely accepted approach. The study of angiogenesis has gained momentum over the last two decades. Although there are various in vitro, ex vivo, and in vivo angiogenesis models that enable testing of newly discovered pro-angiogenic agents, the problem with researching angiogenesis is the choice of the most appropriate assay. In vivo assays are the most representative and reliable models, but they are expensive, time-consuming and can cause ethical concerns whereas in vitro assays are relatively inexpensive, practical, and reproducible, but they are usually lack of enabling the study of more than one aspect of angiogenesis, and they do not fully represent the complexity of physiological angiogenesis. Therefore, there is a need for the development of an angiogenesis model that allows the study of angiogenesis under physiologically more relevant, dynamic conditions without causing ethical concerns. Accordingly, in this study, we developed 3D in vitro dynamic angiogenesis model, and we tested the angiogenic potential of 2-deoxy-D-ribose (2dDR) in comparison with vascular endothelial growth factor (VEGF) using newly developed in vitro 3D dynamic model and well-established in vitro models. Our results obtained using conventional in vitro assays demonstrated that 2dDR promoted proliferation, migration and tube formation of human aortic endothelial cells (HAECs) in a dose-dependent manner. Then, the angiogenic activity of 2dDR was further assessed using the newly developed 3D in vitro model, which enabled the monitoring of cell proliferation and infiltration simultaneously under dynamic conditions. Our results showed that the administration of 2dDR and VEGF significantly enhanced the outgrowth of HAECs and the cellular density under either static or dynamic conditions.
AB - Angiogenesis is a highly ordered physiological process regulated by the interaction of endothelial cells with an extensive variety of growth factors, extracellular matrix components and mechanical stimuli. One of the most important challenges in tissue engineering is the rapid neovascularization of constructs to ensure their survival after transplantation. To achieve this, the use of pro-angiogenic agents is a widely accepted approach. The study of angiogenesis has gained momentum over the last two decades. Although there are various in vitro, ex vivo, and in vivo angiogenesis models that enable testing of newly discovered pro-angiogenic agents, the problem with researching angiogenesis is the choice of the most appropriate assay. In vivo assays are the most representative and reliable models, but they are expensive, time-consuming and can cause ethical concerns whereas in vitro assays are relatively inexpensive, practical, and reproducible, but they are usually lack of enabling the study of more than one aspect of angiogenesis, and they do not fully represent the complexity of physiological angiogenesis. Therefore, there is a need for the development of an angiogenesis model that allows the study of angiogenesis under physiologically more relevant, dynamic conditions without causing ethical concerns. Accordingly, in this study, we developed 3D in vitro dynamic angiogenesis model, and we tested the angiogenic potential of 2-deoxy-D-ribose (2dDR) in comparison with vascular endothelial growth factor (VEGF) using newly developed in vitro 3D dynamic model and well-established in vitro models. Our results obtained using conventional in vitro assays demonstrated that 2dDR promoted proliferation, migration and tube formation of human aortic endothelial cells (HAECs) in a dose-dependent manner. Then, the angiogenic activity of 2dDR was further assessed using the newly developed 3D in vitro model, which enabled the monitoring of cell proliferation and infiltration simultaneously under dynamic conditions. Our results showed that the administration of 2dDR and VEGF significantly enhanced the outgrowth of HAECs and the cellular density under either static or dynamic conditions.
KW - 2-deoxy-D-ribose (2dDR)
KW - PolyHIPE
KW - angiogenesis
KW - angiogenesis assays
KW - emulsion templating
KW - shear stress
KW - thymidine phosphorylase (TP)
KW - vascular endothelial growth factor (VEGF)
UR - http://www.scopus.com/inward/record.url?scp=85078840364&partnerID=8YFLogxK
U2 - 10.3389/fbioe.2019.00451
DO - 10.3389/fbioe.2019.00451
M3 - Article
AN - SCOPUS:85078840364
SN - 2296-4185
VL - 7
JO - Frontiers in Bioengineering and Biotechnology
JF - Frontiers in Bioengineering and Biotechnology
M1 - 451
ER -